Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy: Comparison of insulin glargine with NPH insulin as basal insulin supplement

Diabetes Research and Clinical Practice

Volumn 81, Issue 3, 2008, Pages 290-295

  Plöckinger, Ursula ^a   Topuz, Mendaha ^a   Riese, Brigitte ^a   Reuter, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Exercise; Glargine; Hypoglycaemia; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; ISOPHANE INSULIN; LACTIC ACID;

ADULT; AGED; ARTICLE; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; RISK ASSESSMENT; RISK FACTOR; TREADMILL EXERCISE; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; EXERCISE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; MIDDLE AGED;

EID: 48949087591     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.04.018     Document Type: Article

References (29)

1. Wei M., Gibbons L.W., Mitchell T.L., Kampert J.B., Lee C.D., and Blair S.N. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann. Int. Med. 130 (1999) 89-96
2. Redberg R.F., Greenland P., Fuster V., Pyöräla K., Blair S.N., Folsom A.R., et al. Risk assessment in persons with diabetes. Circulation 108 (2002) e144-e152
3. Zinman B., Ruderman N., Campaigne B.N., Devlin J.T., and Schneider S.H. Physical activity/exercise and diabetes. Diabetes Care 27 Suppl. 1 (2004) 58-62
4. Hu G., Jousilahti P., Barengo N.C., Qiao Q., Lakka T.A., and Tuomilehto J. Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 28 (2005) 799-805
5. Di Loreto C., Fanelli C., Lucidi P., Murdolo G., De Cicco A., Parlanti N., et al. Make your diabetic patients walk. Diabetes Care 28 (2005) 1295-1301
6. Sigal R.J., Kenny G.P., Wasserman D.H., Castaneda-Sceppa C., and White R.D. Physical activity/exercise and type 2 diabetes. Diabetes Care 29 (2006) 1433-1438
7. Jonker J.T., De Laet C., Franco O.H., Peeters A., Mackenbach J., and Nusselder W.J. Physical activity and life expectancy with and without diabetes. Diabetes Care 29 (2006) 38-43
8. Paffenbarger Jr. R.S., Hyde R.T., Wing A.L., Lee I.M., Jung D.L., and Kampert J.B. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N. Engl. J. Med. 328 (1993) 538-545
9. Pate R.R., Pratt M., Blair S.N., Haskell W.L., Macera C.A., Bouchard C., et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. J. Am. Med. Assoc. 273 (1995) 402-407
10. Araiza P., Hewes H., Gashetewa C., Vella C.A., and Burge M.R. Efficacy of a pedometer-based physical activity program on parameters of diabetes control in type 2 diabetes mellitus. Metabol. Clin. Exp. 55 (2006) 1382-1387
11. United Kingdom Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
12. Miller C.D., Phillips L.S., Ziemer D.C., Gallina D.L., Cook C.B., and El-Kebbi I.M. Hypoglycaemia in patients with type 2 diabetes mellitus. Arch. Intern. Med. 161 (2001) 1653-1659
13. DARTS/MEMO Collaboration. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diab. Med. 22 (2005) 749-755
14. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50 (2007) 1140-1147
15. Cryer P.E. Hypoglycemia Pathophysiology Diagnosis and Treatment (1997), Oxford University Press, New York pp. 85-125
16. Cryer P.E., and Childs B.P. Negotiating the barrier of hypoglycemia in diabetes. Diabetes Spectr. 15 (2002) 20-27
17. Goodyear L.J., and Kahn B.B. Exercise, glucose transport and insulin sensitivity. Ann. Rev. Med. 49 (1998) 235-261
18. Holloszy J.O., and Kohrt W.M. Regulation of carbohydrate and fat metabolism during and after exercise. Ann. Rev. Nutr. 16 (1996) 121-138
19. Hilgenfeld R., Dorshug M., and Geisen K. Controlling insulin bioavailability by crystal contact engineering (abstract). Diabetologia 35 Suppl. 1 (1992) A193
20. Coates P.A., Mukherjee S., Luzio S., Srodzinski K.A., Kurzhals R., Roskamp R., et al. Pharmacokinetics of a 'long acting' human insulin analogue (HOE 901) in healthy subjects (abstract). Diabetes 44 Suppl. 1 (1995) 130A
21. Yki-Järvinen H., Dressler A., Ziemen M., and HOE 901/3002 study group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 23 (2000) 1130-1136
22. Rosenstock J., Schwartz S.L., Clark C.M., Park G.D., Donley D.W., and Edwards M.B. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 24 (2001) 631-636
23. Rosenstock J., Dailey G., Massi-Benedetti M., Fritsche A., Lin Z., and Salzman A. Reduced hypoglycemia risk with insulin glargine. Diabetes Care 28 (2005) 950-955
24. Lauer M., Froelicher E.S., Williams M., and Kligfield P. Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association, Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation and Prevention. Circulation 112 (2005) 771-776
25. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 112 (2005) e154-e235
26. Karlsson J., and Jacobs I. Onset of blood lactate accumulation during muscular exercise as a threshold concept: theoretical considerations. Int. J. Sports Med. 3 (1982) 190-201
27. Friedlander A.L., Casazza G.A., Horning M.A., Huie M.J., and Brooks G.A. Training-induced alterations of glucose flux in men. J. Appl. Physiol. 82 (1997) 1360-1369
28. Spurway N.C. Aerobic exercise, anaerobic exercise and the lactate threshold. Br. Med. Bull. 48 (1992) 569-591
29. Reuter T., Topuz M., Riese B., et al. Risk of exercise induced hypoglycemia in patients with diabetes mellitus type 2 (DM2) on intensified insulin therapy (ICT). Comparison of NPH-insulin versus glargine as basal insulin. Diabetologia 48 Suppl. 1 (2005) A857